Aug. 19, 2014

3D printing company Oxford Performance Materials (OPM) today announced that it has received 510(k) clearance from the FDA for its 3D printed OsteoFab Patient-Specific Facial Device (OPSFD).

OPM's facial device is the first and only FDA cleared 3D printed polymeric implant for facial indications. The OPSFD will be 3D printed by OPM Biomedical, utilizing the company's OsteoFab process, which combines laser sintering additive manufacturing technology with the EOSINT P 800 printer and OPM's polymer poly-ether-ketone-ketone (PEKK) powder formulation to print orthopedic and neurological implants. These implants are biocompatible, mechanically similar to bone, radiolucent, and support bone attachment (i.e. osteoconductive).

In February 2013, OPM received FDA 510(k) clearance for the OsteoFab Patient Specific Cranial Device (OPSCD). The OPSCD is manufactured from PEKK. That was the first 3D printed, non-metal implant to receive this approval.

"There has been a substantial unmet need in personalized medicine for truly individualized - yet economical - solutions for facial reconstruction, and the FDA's clearance of OPM's latest orthopedic implant marks a new era in the standard of care for facial reconstruction," said Scott DeFelice, Chief Executive Officer and Chairman of Oxford Performance Materials.

"Until now, a technology did not exist that could treat the highly complex anatomy of these demanding cases. With the clearance of our 3D printed facial device, we now have the ability to treat these extremely complex cases in a highly effective and economical way, printing patient-specific maxillofacial implants from individualized MRI or CT digital image files from the surgeon. This is a classic example of a paradigm shift in which technology advances to meet both the patient's needs and the cost realities of the overall healthcare system."

OPM technology is also designed to reduce the overall "cost of ownership" to the customer by decreasing operating room time, hospital length of stay and procedure complications. In addition, OsteoFab customers do not pay a premium for the individualized 3D printed implant.

This week, OPM was named the "Best Global Company for 3-D Healthcare Innovation" by The New Economy Awards for the company's development of additive manufacturing techniques with the ultra-high performance PEKK.

"An exciting aspect of our technology is that additional complexity does not increase manufacturing cost, and having both cranial and facial devices cleared now enables us to answer ever more complex cases where upper facial structures can be incorporated with cranial implants as a single device," added Severine Zygmont, President of OPM Biomedical.

"As a result, additive manufacturing has the potential to not only improve patient outcomes, but fundamentally improve the economics of orthopedics on a global scale – for developed and developing countries. These are disruptive changes that will allow the industry to provide the finest levels of healthcare to more people at a lower cost."

Biomet, Inc., a leading distributor of advanced technologies for the treatment of arthritis, joint and spine related injuries and facial reconstruction, will be the exclusive global distributor of OPM's OPSFD.


Posted in 3D Printing Applications

Maybe you also like:


Joe Roberts wrote at 8/21/2014 4:06:07 AM:


alvaro wrote at 8/20/2014 4:25:55 AM:

A revolution!

Leave a comment:

Your Name:


Subscribe us to Feeds twitter facebook   

About provides the latest news about 3D printing technology and 3D printers. We are now seven years old and have around 1.5 million unique visitors per month.

News Archive